InvestorsHub Logo
Followers 44
Posts 5658
Boards Moderated 0
Alias Born 10/28/2009

Re: SkiMan85 post# 513

Friday, 09/29/2017 11:35:01 AM

Friday, September 29, 2017 11:35:01 AM

Post# of 13632
That pr did state the 3rd quarter sales would receive a boost and personally I believe FDA approval surgical use is near. The military field trials I understand went well. The pps is undervalued and a buyout offer from Barnett is possible as well?
.55 short term IMO!